Markets:

Overview

News

Currencies

International

Treasuries

Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

12.18 +0.92 (+8.13%)

Delayed Quote Updated: 3:16 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Intellia Therapeutics, Inc. - Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Global Glioblastoma Multiforme (GBM) Treatment Market Could Reach Nearly $1.8 Billion By 2027

June 29, 2021

Via FinancialNewsMedia

10 Biggest Price Target Changes For Tuesday ↗

June 29, 2021

Barclays raised the price target for Skyworks Solutions, Inc. (NASDAQ:

Via Benzinga

22 Stocks Moving in Tuesday's Pre-Market Session ↗

June 29, 2021

Gainers Exela Technologies, Inc. (NASDAQ: XELA) rose 39% to $2.05 in pre-market trading after gaining over 5% on Monday. Marin Software Incorporated (NASDAQ: MRIN) rose 36.8% to...

Via Benzinga

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout ↗

June 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28) Alexion Pharmaceuticals,...

Via Benzinga

Intellia Seeks To Raise $400M Via Equity ↗

June 29, 2021

Intellia Therapeutics Inc (NASDAQ: NTLA) commenced an underwritten public offering of $400 million shares of its common stock. Underwriters have an option to...

Via Benzinga

Intellia Therapeutics Analyst Doubles Price Target: What You Need To Know ↗

June 28, 2021

An SVB Leerink genetic medicine analyst is bullish on shares of Intellia Therapeutics, Inc. (NASDAQ:

Via Benzinga

60 Biggest Movers From Yesterday ↗

June 29, 2021

Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its...

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher ↗

June 28, 2021

Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has...

Via Benzinga

Topics Stocks

Intellia Makes a Splash, Bringing Other CRISPR Stocks Along for the Ride ↗

June 28, 2021

Intellia's recent press release reveals first-of-its-kind clinical results for genome editing technology, leading NTLA stock skyward.

Via InvestorPlace

Ignoring Monday's 2 Big Nasdaq Winners Could Cost You Serious Money ↗

June 28, 2021

Find out why these stocks are climbing higher.

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 28, 2021

Gainers Intellia Therapeutics (NASDAQ:NTLA

Via Benzinga

Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump ↗

June 28, 2021

Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the...

Via Benzinga

Topics Stocks

Why Beam Therapeutics Jumped Today ↗

June 28, 2021

A first for CRISPR-Cas9 might signal a new phase in the gene-editing revolution.

Via The Motley Fool

Why Editas Medicine Stock Is Jumping Today ↗

June 28, 2021

Good news for Intellia was viewed as good news for Editas.

Via The Motley Fool

44 Stocks Moving In Monday's Mid-Day Session ↗

June 28, 2021

Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software...

Via Benzinga

Why Intellia Therapeutics Stock Is Skyrocketing Today ↗

June 28, 2021

The company reported promising interim trial results for its CRISPR gene-editing candidate.

Via The Motley Fool

Intellia Stock Leads Biotech Rally On Historic Moment For CRISPR ↗

June 28, 2021

Intellia led a rally for CRISPR stocks on Monday on early promise for its gene-editing drug. The news sent NTLA stock to a record high.

Via Investor's Business Daily

Stocks That Hit 52-Week Highs On Monday ↗

June 28, 2021

During the morning session on Monday, 118 stocks hit new 52-week highs. Highlights: The company with the largest market cap to set a new 52-week high was Microsoft...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook ↗

June 28, 2021

Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S....

Via Benzinga

Topics Stocks

Why Intellia Therapeutics Stock Is Soaring Today ↗

June 28, 2021

Intellia Therapeutics Inc (NASDAQ:NTLA) is trading signifi...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

June 28, 2021

Barclays raised the price target for Accenture plc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 28, 2021

Gainers Intellia Therapeutics (NASDAQ:NTLA) stock rose 62.0% to $143.91 during Monday's pre-market session. The company's market cap stands at $9.8 billion....

Via Benzinga

Gene Editing Stocks: The Big News Lifting EDIT, BNGO, CRSP and NTLA Stocks ↗

June 28, 2021

Gene editing stocks, led by NTLA stock, are powering higher on Monday following a landmark announcement by Intellia Therapeutics.

Via InvestorPlace

24 Stocks Moving in Monday's Pre-Market Session ↗

June 28, 2021

Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim...

Via Benzinga

Intellia Shares Shoot Higher On Promising Biomarker Data From CRISPR/Cas9 Genome Editing Candidate ↗

June 28, 2021

Intellia Therapeutics Inc (NASDAQ: NTLA) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have announced positive interim data from an ongoing Phase 1...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower ↗

June 28, 2021

Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged more than 230 points in the previous session. The S&P 500 index also...

Via Benzinga

Topics Stocks

Expert Ratings For Intellia Therapeutics ↗

June 23, 2021

Within the last quarter, Intellia Therapeutics (NASDAQ:NTLA) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago 3 Months Ago Bullish 0 1 1...

Via Benzinga

Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics Launch New CAR T-Cell Company

June 22, 2021

From Blackstone

Via Business Wire

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗

June 20, 2021

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.

Via Talk Markets

The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs ↗

June 20, 2021

Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.